Patents by Inventor Cecilia G. Unson

Cecilia G. Unson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucagon analogs with serine replacements
    Patent number: 5665705
    Abstract: Glucagon analogs characterized principally by substitution of amino acid residues at positions 9, 11, 16, and 21 with or without a histidine residue at the amino terminus are useful adjuncts to insulin therapy.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 9, 1997
    Assignee: The Rockefeller University
    Inventors: Robert B. Merrifield, Cecilia G. Unson
  • Glucagon analogs with serine replacements
    Patent number: 5480867
    Abstract: Glucagon analogs characterized principally by the removal or replacement of the 9-aspartic acid residue or its replacement with another amino acid residue together with replacement of the 16-serine residue and possible replacement of the 11-serine residue and 21-aspartic acid residue with or without a histidine at the amino terminal are useful adjuncts to insulin therapy.
    Type: Grant
    Filed: June 8, 1994
    Date of Patent: January 2, 1996
    Assignee: The Rockefeller University
    Inventors: Robert B. Merrifield, Cecilia G. Unson
  • Glucagon analogs with ASP.sup.9 replacements or deletions
    Patent number: 5143902
    Abstract: Glucagon analogs characterized principally by the removal of the 9-aspartic acid residue or its replacement with an amino acid residue other than an L- dibasic amino acid containing up to five carbon atoms with or without a histidine at the amino terminal are useful adjuncts to insulin therapy.
    Type: Grant
    Filed: December 16, 1991
    Date of Patent: September 1, 1992
    Assignee: The Rockefeller University
    Inventors: Robert B. Merrifield, Cecilia G. Unson